SCHEMBL7424973

SCHEMBL7424973

CC(=O)NCC(=O)[C@@H](Cc1ccccc1)c1cccc(C(N)=O)c1Oc1ccccc1

nearest known ligand 0.40

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.40
MTNR1B P49286 3/20 0.40
CTNNB1 P35222 1/20 0.38
SIRT2 Q8IXJ6 3/20 0.36
SIRT1 Q96EB6 1/20 0.36
ACACB O00763 1/20 0.36
EPHX1 P07099 1/20 0.35
MAPK8 P45983 1/20 0.35
AURKA O14965 2/20 0.35
RPS6KB1 P23443 2/20 0.35
AURKB Q96GD4 1/20 0.35
PPARG P37231 2/20 0.34
PPARA Q07869 2/20 0.34
NPY5R Q15761 2/20 0.34
FFAR1 O14842 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7426429 0.86 SIRT2 (0.41) CTNNB1SIRT2SIRT1EPHX1AURKA
SCHEMBL7694696 0.69 KDM4E (0.47) MAPK8PPARA
SCHEMBL8211650 0.66 CTNNB1 (0.54) CTNNB1SIRT2SIRT1AURKARPS6KB1
SCHEMBL27464948 0.65 CTNNB1 (0.53) MTNR1ACTNNB1SIRT2SIRT1MAPK8
SCHEMBL5049439 0.64 CTNNB1 (0.59) CTNNB1SIRT2SIRT1MAPK8
SCHEMBL27872615 0.63 CTNNB1 (0.57) CTNNB1SIRT2SIRT1MAPK8
SCHEMBL27991301 0.63 CTNNB1 (0.57) CTNNB1SIRT2SIRT1MAPK8
SCHEMBL20178657 0.63 EPHX1 (0.47) SIRT2EPHX1
SCHEMBL28081509 0.62 BCAT2 (0.61) CTNNB1SIRT2SIRT1AURKARPS6KB1
SCHEMBL5175235 0.62 CTNNB1 (0.59) CTNNB1SIRT2SIRT1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1073632-A1 SUBSTITUTED BENZAMIDES, THEIR PRODUCTION AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 2001-02-07 EP disclosed
WO-1999054293-A1 SUBSTITUTED BENZAMIDES, THEIR PRODUCTION AND THEIR USE AS CYSTEINE PROTEASE INHIBITORS BASF AKTIENGESELLSCHAFT (DE) 1999-10-28 WO disclosed